Parts Manufactured by this CAGE Code 1F095
The Commercial And Government Entity Code 1F095 refers to the manufacturer Schering Plough Ltd. Owned and operated by ASAP Semiconductor, Parts Needed yesterday stocks multiple parts from Schering Plough Ltd, such as NDC00085-0720-04, NDC00085-0077-05, NDC00085 0285 02, NDC00085 3320 35, NDC00085-0362-06. Our team at ASAP can cross-reference CAGE codes with NSN numbers to remove confusion and simplify the parts procurement process for our customers. If you want to get started, you can fill out the Instant RFQ form for CAGE Code 1F095 on this page.
Manufacturer for CAGE Code 1F095
Part Numbers List for CAGE Code 1F095
Part No | Item Name | NSN | QTY | RFQ |
---|---|---|---|---|
NDC00085-0720-04 | perphenazine and am | 6505-01-028-1189 | Avl | RFQ |
NDC00085-0077-05 | perphenazine tablet | 6505-01-271-7666 | Avl | RFQ |
NDC00085 0285 02 | interferon alpha 2b recombinant for injection | 6505-01-246-3793 | Avl | RFQ |
NDC00085 3320 35 | nitroglycerin trans | 6505-01-157-9064 | Avl | RFQ |
NDC00085-0362-06 | labetalol hydrochlo | 6505-01-257-9990 | Avl | RFQ |
NDC11523 7160 02 | loratadine tablets | 6505-01-505-0915 | Avl | RFQ |
NDC00085-0517-04 | betamethasone dipro | 6505-01-269-6738 | Avl | RFQ |
NDC00085-0728-01 | betamethasone dipro | 6505-01-233-1901 | Avl | RFQ |
NDC00085-0244-05 | labetalol hydrochlo | 6505-01-218-7437 | Avl | RFQ |
NDC00085-0933-10 | theophylline extend | 6505-01-070-0821 | Avl | RFQ |
NDC00085-0487-01 | theophylline extend | 6505-01-037-5613 | Avl | RFQ |
NDC00085 0567 01 | mometasone furoate | 6505-01-270-5963 | Avl | RFQ |
NDC00085-0263-01 | potassium chloride extended release tablets usp | 6505-01-280-3014 | Avl | RFQ |
NDC00085-0525-03 | flutamide capsules usp | 6505-01-329-6495 | Avl | RFQ |
NDC00085 0002 03 | betamethasone valerate lotion usp | 6505-00-515-8638 | Avl | RFQ |
NDC00085 1777 01 | ciprofloxacin oral | 6505-01-492-8089 | Avl | RFQ |
REBETRON 600 | ribavirin and interferon combination pack | 6505-01-497-7883 | Avl | RFQ |
NDC00085-0438-06 | labetalol hydrochloride tablets usp | 6505-01-319-5118 | Avl | RFQ |
NDC00085 0362 08 | labetalol hydrochlo | 6505-01-285-0171 | Avl | RFQ |
NDC00085-0370-02 | mometasone furoate | 6505-01-269-6727 | Avl | RFQ |
NDC00085-0787-01 | potassium chloride | 6505-01-266-8634 | Avl | RFQ |
K-DUR 10 | potassium chloride extended release tablets usp | 6505-01-280-3014 | Avl | RFQ |
ETRAFON 4-25 | perphenazine and am | 6505-01-296-3183 | Avl | RFQ |
NDC00085-0584-81 | theophylline extend | 6505-01-073-1552 | Avl | RFQ |
NDC00085-0517-01 | betamethasone dipropionate cream usp | 6505-01-269-6737 | Avl | RFQ |
NDC00085-0752-07 | labetalol hydrochloride tablets usp | 6505-01-319-6667 | Avl | RFQ |
NDC00085-1737-01 | moxifloxacin hydroc | 6505-01-503-7443 | Avl | RFQ |
NDC00085-4110-03 | isosorbide mononitrate extended release tablets | 6505-01-388-2487 | Avl | RFQ |
CLARITIN ALLERGY 24 HOUR | loratadine tablets | 6505-01-505-0915 | Avl | RFQ |
NDC00085-0787-81 | potassium chloride | 6505-01-266-8634 | Avl | RFQ |
ETRAFON 2-25 | perphenazine and amitriptyline hydrochloride table | 6505-01-342-9196 | Avl | RFQ |
NDC00085-0074-05 | sulfacetamide sodium and prednisolone acetate opht | 6505-01-149-3562 | Avl | RFQ |
NDC00085-0705-04 | perphenazine tablets usp | 6505-01-217-1242 | Avl | RFQ |
NDC00085-0475-06 | betamethasone dipro | 6505-01-163-4131 | Avl | RFQ |
NDC00085-0438-03 | labetalol hydrochlo | 6505-01-197-4180 | Avl | RFQ |
NDC00085-0362-09 | labetalol hydrochloride injection usp | 6505-01-319-5119 | Avl | RFQ |
NDC00085 0819 35 | nitroglycerin transdermal system | 6505-01-409-2737 | Avl | RFQ |
NDC00085-1179-02 | interferon alpha 2b recombinant for injection | 6505-01-366-7515 | Avl | RFQ |
NDC00085-0263-81 | potassium chloride | 6505-01-284-9218 | Avl | RFQ |
NDC00085-0444-05 | tolnaftate powder u | 6505-01-037-6536 | Avl | RFQ |
NDC00085-0566-05 | betamethasone sodiu | 6505-00-904-2190 | Avl | RFQ |
NDC11523-7160-08 | loratadine tablets | 6505-01-524-9179 | Avl | RFQ |
NDC00085-3330-35 | nitroglycerin transdermal system | 6505-01-357-5371 | Avl | RFQ |
NDC00085 0614 02 | albuterol inhalatio | 6505-01-116-9245 | Avl | RFQ |
NDC00085-0296-05 | fluphenazine hydroc | 6505-00-904-2182 | Avl | RFQ |
NDC00085-0096-05 | vitamin a and vitam | 6505-01-141-0826 | Avl | RFQ |
NDC00085-0598-04 | perphenazine and amitriptyline hydrochloride table | 6505-01-342-9196 | Avl | RFQ |
INTRON A PAK-3 | interferon alpha 2b recombinant for injection | 6505-01-349-3539 | Avl | RFQ |
NDC00085-0337-03 | gentamicin sulfate | 6505-01-234-4446 | Avl | RFQ |
00085-4110-03 | isosorbide mononitrate extended release tablets | 6505-01-388-2487 | Avl | RFQ |
NDC00085-0571-02 | interferon alpha 2b recombinant for injection | 6505-01-246-3792 | Avl | RFQ |
8564621 | lidocaine hydrochlo | 6505-01-554-7880 | Avl | RFQ |
NDC00085-0201-05 | diazoxide injection | 6505-00-334-4478 | Avl | RFQ |
NDC00085 0370 01 | mometasone furoate | 6505-01-269-6729 | Avl | RFQ |
NDC00085-0720-08 | perphenazine and am | 6505-01-296-3183 | Avl | RFQ |
NDC00085-3315-35 | nitroglycerin trans | 6505-01-357-5373 | Avl | RFQ |
NDC00085 0819 30 | nitroglycerin transdermal system | 6505-01-409-2737 | Avl | RFQ |
INTRON A PAK 10 | interferon alpha 2b recombinant for injection | 6505-01-366-7515 | Avl | RFQ |
NDC00085-0752-08 | labetalol hydrochloride tablets usp | 6505-01-319-5117 | Avl | RFQ |
NDC00085 0539 01 | interferon alpha 2b recombinant for injection | 6505-01-351-9262 | Avl | RFQ |
NDC00085-0787-06 | potassium chloride extended release tablets usp | 6505-01-318-5737 | Avl | RFQ |
NDC00085-0933-01 | theophylline extend | 6505-01-083-6613 | Avl | RFQ |
NDC00085-1236-03 | ribavirin and interferon combination pack | 6505-01-497-7883 | Avl | RFQ |
NDC00085-0584-01 | theophylline extend | 6505-01-037-5607 | Avl | RFQ |
NDC00085-4110-01 | isosorbide mononitrateextended release tablets | 6505-01-383-7339 | Avl | RFQ |
NDC00085-0363-02 | perphenazine oral solution usp | 6505-01-272-2379 | Avl | RFQ |
NDC00085-3320-35 | nitroglycerin transdermal system | 6505-01-357-5372 | Avl | RFQ |
NDC00085-3305-35 | nitroglycerin transdermal system | 6505-01-357-5370 | Avl | RFQ |
NDC00085-0510-04 | betamethasone dipro | 6505-01-034-3651 | Avl | RFQ |
NDC00085-0151-05 | gentamicin sulfate | 6505-00-432-1065 | Avl | RFQ |
NDC00085-0096-01 | vitamin a and vitam | 6505-00-064-0990 | Avl | RFQ |
NDC00085-3320-30 | nitroglycerin trans | 6505-01-237-5373 | Avl | RFQ |
NDC00085-0567-02 | mometasone furoate | 6505-01-269-6728 | Avl | RFQ |
NDC00085 0510 06 | betamethasone dipropionate ointment usp | 6505-01-035-6358 | Avl | RFQ |
NDC00085-0806-01 | theophylline extend | 6505-01-272-5114 | Avl | RFQ |
NDC00085-0647-05 | interferon alpha 2b recombinant for injection | 6505-01-349-3539 | Avl | RFQ |
NDC00085-1133-01 | interferon alpha 2b recombinant injection | 6505-01-377-1460 | Avl | RFQ |
NDC00085-0924-02 | clotrimazole and be | 6505-01-243-5901 | Avl | RFQ |
NDC00085-0525-06 | flutamide capsules usp | 6505-01-377-1443 | Avl | RFQ |
NDC00085-0525-05 | flutamide capsules | 6505-01-317-0302 | Avl | RFQ |
NDC00085-0458-05 | loratadine tablets | 6505-01-377-1461 | Avl | RFQ |
NDC00085-0525-04 | flutamide capsules | 6505-01-306-1728 | Avl | RFQ |
NDC00085-0598-08 | perphenazine and am | 6505-01-299-9141 | Avl | RFQ |
NDC00085-0120-02 | interferon alpha 2b | 6505-01-246-3791 | Avl | RFQ |
NDC00085-0819-35 | nitroglycerin transdermal system | 6505-01-396-1314 | Avl | RFQ |
NDC00085-0244-08 | labetalol hydrochloride tablets usp | 6505-01-218-7436 | Avl | RFQ |
NDC00085-0691-02 | ceftibuten capsules | 6505-01-435-9294 | Avl | RFQ |
NDC00085 0259 02 | beclomethasone dipr | 6505-01-275-4812 | Avl | RFQ |
NDC00085-1132-01 | albuterol sulfate i | 6505-01-538-2871 | Avl | RFQ |
NDC00085-3320-30 | nitroglycerin trans | 6505-01-157-9064 | Avl | RFQ |
NDC00085-0571-06 | interferon alpha 2b recombinant for injection | 6505-01-366-7515 | Avl | RFQ |